The NTCI treatment reduced the expression of the genes encoding fibrinogen chains and Factor X in the lungs and kidneys thereby potentially reducing the risk of DIC in sepsis, and by extension, in thrombophilia. This evidence concerns the gene F10 and Sepsis.